According to #TechSci Research report,
Vietnam
Pharmaceuticals Market has shown promising
growth by 2019 and is expected to continue its growth in upcoming forecast
years 2021 to 2026.
Get Sample Report: https://bit.ly/33iGUzw
Press Release: https://bit.ly/3qhtk8o
Website: https://www.techsciresearch.com/
Market Research News: https://techsciblog.com/
According to #TechSci Research report,
Vietnam
E-Pharmacy Market has shown promising growth until 2019
and is expected to continue its growth in upcoming forecast years 2021 to 2026.
Get Sample Report: https://bit.ly/332Bfxk
Press Release: https://bit.ly/3t33ffc
Website: https://www.techsciresearch.com/
Market Research News: https://techsciblog.com/
According to #TechSci Research report, United States E-Pharmacy Market has shown promising growth until 2019 and is expected to continue its growth in upcoming forecast years 2021 to 2026.
Gain More Insight: https://bit.ly/32Bgbyl
Get Sample Report: https://bit.ly/32WRNql
Press Release: https://bit.ly/3HvBujr
Website: https://www.techsciresearch.com/
Market Research News: https://techsciblog.com/
Increasing prevalence of cardiovascular diseases and diabetes is driving the growth of United States generic drugs market in the forecast period, 2022-2026.
The growing geriatric population across the country which is susceptible to various infectious and non-infectious diseases is expected to drive the market growth over the next few years. Additionally, increasing number of patents losing their exclusivity has led to a lot of generic drugs manufacturers emerging out and developing generic drugs, thereby positively influencing the market growth during the forecast period. Furthermore, the FDA stated that around 158 drug patents would expire in 2021, thereby increasing the market potential for generic drugs.
However, stringent regulatory approval process by the FDA and product recalls can restrain the market growth over the next few years. Furthermore, growing competition in the market along with shortage of medicines can slow down the growth of generic drugs in the United States. Also, the prescription of drugs by doctors also plays a pivotal role in the demand of generic drugs since most doctors prescribe branded drugs, thereby hampering the market growth over the next few years.
Browse over 21 market data Figures spread through 70 Pages and an in-depth TOC on "United States Generic Drugs Market"
https://www.techsciresearch.com/report/united-states-generic-drugs-market/7595.html
The United States generic drugs market is segmented based on type, application, mode of drug delivery, form, source, distribution channel, regional distribution, and company. In terms of application, the market can be categorized into cardiovascular diseases, diabetes, neurology, oncology, infectious diseases, and others.
The cardiovascular diseases segment dominated the market in 2020 with an overall market share of 36.73% on account of the increasing cases of cardiovascular diseases due to unhealthy eating habits and sedentary lifestyles. Based on form, the market can be categorized into tablet, capsule, injection, and others. The injection segment is expected to witness significant growth during the forecast period since administration of drug through this mode of administration increases the bioavailability of drug.
By distribution channel, the market can be fragmented into retail pharmacies, online pharmacies, hospital pharmacies and others. The retail pharmacies segment is expected to dominate the market since most of the generic drugs can be purchased through retail pharmacies over the counter.
Key market players in the United States generic drugs market include:
Major companies operating in the market are following strategies such as mergers & acquisitions, product launches, among others in order to stay competitive in the market and having an edge over other players operating in the market.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7595
Customers can also request for 10% free customization on this report.
“The South region will register the fastest CAGR during the forecast period. This can be attributed to the large and growing cardiovascular and diabetic patients in the region, which is susceptible to different kinds of diseases. Additionally, supportive government policies and healthcare schemes launched in the United States are expected to support market growth.”, said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“United States Generic Drugs Market By Type (Small Molecule Generics v/s Biosimilars), By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Infectious Diseases, Others), By Mode of Drug Delivery (Oral, Topical, Parenteral, Others), By Form (Tablet, Capsule, Injection, Others), By Source (In House v/s Contract Manufacturing Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Region, Competition, Forecast and Opportunity, 2026”, has evaluated the future growth potential of United States generic drugs market and provides statistics and information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the United States generic drugs market.
Browse Related Reports:
Global Cholesterol Testing Market By Indication (Atherosclerosis, Diabetes, Obesity, Others), By Product (Test Strips, Test Kits), By End-Product (Total cholesterol, High-density lipoprotein cholesterol, Low-density lipoprotein cholesterol, Triglycerides), By Test (Lipid Panel Test, Apolipoprotein B Test, Others), By Age (Before Puberty, Puberty, Adulthood), By End-User (Hospitals & Clinics, Homecare, Others), By Region, Forecast & Opportunities, 2025
https://www.techsciresearch.com/report/cholesterol-testing-market/4663.html
Global Creatinine Assay Market By Disease (Type 1 Diabetes, Type 2 Diabetes, Kidney disease, Others), By Method (O'Leary modified Jaffe assay, Jaffe, Enzymatic),By Kit (Creatinine-pap test kits, ELISA test kits, Jaffe’s kinetic test kits, Creatinine Colorimetric/Fluorometric Assay Kit), By Sample (Serum, Urine, Cerebrospinal fluid (CSF), Others), By End-User (Hospitals and clinics, Diagnostic laboratories, Others), By Region, Forecast & Opportunities, 2025
https://www.techsciresearch.com/report/creatinine-assay-market/4535.html
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: sales@techsciresearch.com
Website: https://www.techsciresearch.com/
For More Market Research Blogs Visit: https://techsciblog.com/
Increasing instances of diabetes is driving the growth in the global insulin pills market in the forecast period, 2022-2026.
Moreover, prevalence of the extended research and technological advances to formulate innovative pharmaceutical products as a treatment for the diseases as well as to contain the symptoms, the futuristic growth of global insulin pills market in expected in the next five years. Additionally, increasing patient compliance toward oral administration of the diabetes drugs is expected to aid the growth of the global insulin pills market in the future five years.
Also, increasing awareness and preferences toward using insulin pills instead of injections along with the advantages of the insulin pills over injections is substantiating the growth of the global insulin pills market in the forecast years, until 2026.
Although higher cost of the pharmaceutical and dependency over the drug might hinder with the growth of the global insulin pills market, but initiatives by several market players that are already dominating the pharmaceutical sector may support the growth and reinstate the futuristic growth of the global insulin pills market in the forecast period, 2022-2026.
Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on "Global Insulin Pills Market"
https://www.techsciresearch.com/report/insulin-pills-market/8025.html
The global insulin pills market is segmented on the basis of form, type of insulin, competitional landscape, and regional distribution. Based on form, the market is further fragmented into tablet, and capsule. Tablets are anticipated to hold the largest revenue shares of the market in the upcoming five years on the grounds of its easier administration when compared to capsule forms of the drugs, and thus dominate the market segmentation too.
Moreover, increasing number of children population with diabetes is surging the demand for the tablets since they are easier to digest for them and even for the administration. Moreover, injections of insulin to the younger population are difficult and non-feasible thus oral insulin drugs are more preferential, thereby aiding the growth of the sub-segment and driving the growth of the global insulin pills market in the next five years.
Capsules are also expected to register significant growth in the future five years on the account of the added advantage of the capsules, that they deliver the drug directly into the target organ and protects the drug from the gastro-intestinal tract. Oramed Pharmaceuticals Inc. discovered a way to convert injectable medications into oral treatments, culminating in a breakthrough technology which protects the peptide as it enters the gastrointestinal tract with a special coating, while pharmacology (protease inhibitors) stops protein-degrading gut enzymes from damaging the drug.
Additionally, absorption enhancers help the peptides cross the small intestine wall. These functions that are feasible due to capsules and the factor is actively influencing the future growth of the global insulin pill market in the forecast years.
List of major market players of the global insulin pills market includes:
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=8025
Customers can also request for 10% free customization on this report.
“North America region is anticipated to dominate the regional market analysis in the upcoming five years on the grounds of increasing number of patients suffering from abnormal blood sugar levels. Moreover, countries like United States and Canada in the North America region have a well-established healthcare sector that is a major factor influencing the growth of the market. Also, increasing development of the innovative pharmaceutical to combat blood sugar disorders is further substantiating the growth of the global insulin pill market in the future five years. Market players like Oramed Pharmaceutical Inc. are conducting number of clinical trials for the ORMD-0801 drug as an insulin pill and its approaching approvals from US-FDA shows probable increasing number of pharmaceutical products that are expected to be launched and commercialized in next few years, further aiding to the growth of the global insulin pill market in the forecast years. New market players may form mergers and acquisitions with the established market players and dominators of the pharmaceutical industry thus establishing their brand value in the market,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Global Insulin Pills Market - Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2016-2026 Segmented By Form (Tablet v/s Capsule), By Type of Insulin (Long-Acting Insulin, Short-Acting Insulin, Rapid-Acting Insulin), By Region”, has evaluated the future growth potential of global insulin pills and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global insulin pills market.
Browse Related Reports:
Global Nuclear Medicine Market By Type (Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine, Brachytherapy Isotopes), By Diagnostic Nuclear Medicine (SPECT Radiopharmaceuticals v/s PET Radiopharmaceuticals), By Therapeutic Nuclear Medicine (Alpha Emitters v/s Beta Emitters), By Application (Diagnostic Applications v/s Therapeutic Applications), By Diagnostic Applications (SPECT Applications v/s PET Applications), By Therapeutic Applications (Thyroid Indications, Bone Metastasis, Lymphoma, Endocrine Tumors, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutions), By Region, Forecast & Opportunities, 2026
https://www.techsciresearch.com/report/nuclear-medicine-market/4562.html
Global Formulation Development Outsourcing Market By Services (Pre-Formulation Services {Discovery & Preclinical Services v/s Analytical Services} v/s Formulation Optimization {Phase I, Phase II, Phase III, Phase IV}) By Dosage Form (Oral, Topical, Intravenous, Others) By Application (Oncology, Genetic Disorders, Neurology, Infectious Diseases, Respiratory, Cardiovascular, Others) By End User (Pharmaceutical & Biopharmaceutical Companies, Governments, Academic & Research Institutions, Others) By Region, Competition Forecast & Opportunities, 2026
https://www.techsciresearch.com/report/formulation-development-outsourcing-market/7747.html
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: sales@techsciresearch.com
Website: https://www.techsciresearch.com/
For More Market Research Blogs Visit: https://techsciblog.com/
Advancing pharmaceutical industry is driving the growth of global specialty pharmacy market in the forecast period, 2022-2026.
According to TechSci Research report, “Specialty Pharmacy Market - Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2016-2026”, the global specialty pharmacy market would potentially project an impressive growth in the forecast period, 2022-2026, with an impressive CAGR on the account of increasing demands for the specialty medicine for the rare diseases. Increasing instances of the rare disease is further driving the growth of the global specialty pharmacy market in the upcoming five years. Moreover, increased financial investment in the healthcare industry is also supporting the growth of the global specialty pharmacy market in the next five years.
Consistent research and advanced technologies are further aiding the growth of the global specialty pharmacy market in the future five years. Increasing expenses of pharmaceuticals in the recent times and increasing number of patients demanding special medical attention for the deteriorating conditions due to rare diseases like cancer, rheumatoid arthritis, hemophilia, hepatitis C, multiple sclerosis, etc. is further supporting the growth of the global specialty pharmacy market in the forecast years, until 2026.
Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on "Global Specialty pharmacy Market"
https://www.techsciresearch.com/report/specialty-pharmacy-market/8024.html
The global specialty pharmacy market is segmented on the basis of ownership, therapy area, competitional landscape, and regional distribution. Based on ownership, the market is further fragmented into standalone, hospital-based, and others. Hospital-based ownership of the specialty pharmacy is anticipated to hold the largest revenue shares of the market in the upcoming five years on the backbone of high cost of setting up a specialty pharmacy.
The specialty pharmacy is set up for the storage and sale of specialty medicine that are responsible for the cure of rare and chronic diseases. Moreover, for the fulfilment of demand of the drugs for rare diseases and the patients suffering from the diseases are often under patient care from the hospitals. Thus, hospital-based specialty pharmacy is a necessity for growing healthcare services in the hospitals.
Stand-alone specialty pharmacy is also anticipated to register significant growth in the next five years on the grounds of increasing financial investments in the healthcare sector. Government is taking initiatives to invest in the growth of specialty pharmacies in various regions. Financial aids to the healthcare centers and pharmaceutical companies for the development of specialty pharmacy are further aiding to the growth of the global specialty pharmacy market in the future five years.
On the basis of therapy area, the market is bifurcated into cancer, rheumatoid arthritis, hemophilia, hepatitis C, multiple sclerosis, and others. Cancer pharmaceutical products are anticipated to register largest revenue shares of the market in the upcoming five years on the account of increasing instances of cancer patients. Rapidly increasing types of cancer patients and its tendency to retaliate even after treatments is anticipated to support the growth of the global specialty pharmacy market in the next five years.
A partial list for the market dominators of the specialty pharmacy market includes:
The market players are working towards forming a reputed distribution channel for pharmaceutical supplies for rare diseases.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=8024
Customers can also request for 10% free customization on this report.
“North America is anticipated to dominate the market in the upcoming five years on the ground of well-established healthcare industry in the region. United States is expected to support the growth with its advanced healthcare services and one of the largest healthcare sectors in the world. Moreover, increasing number of specialty pharmacy in the region supports the growth in the next five years. The country also supports budding market players who are entering the market with its relaxed regulations. Furthermore, increasing acceptance and FDA approvals for the storage conditions is aiding the growth of the global specialty pharmacy in the global specialty pharmacy market in the future five years. New market players are advised to focus their resources and financial aids in the research institutes to improve the storage conditions of the specialty medicines,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Global Specialty Pharmacy Market - Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2016-2026 Segmented By Ownership (Standalone, Hospital-Based, Others), By Therapy Area (Cancer, Rheumatoid Arthritis, Hemophilia, Hepatitis C, Multiple Sclerosis, Others), By Region”, has evaluated the future growth potential of global specialty pharmacy and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global specialty pharmacy market.
Browse Related Reports:
Global Anti-Fungal Drugs Market By Drug Class (Azoles, Echinocandins, Polyenes, Allylamines, Others), By Indication (Candidiasis, Aspergillosis, Mucormycosis, Dermatophytosis, Others), By Infection Type (Superficial Fungal Infection, Systemic Fungal Infection), By Route of Administration (Topical, Oral, Parenteral, Others), By End User (Homecare, Hospitals, Clinics, Others) By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), By Region, Competition Forecast & Opportunities, 2026
https://www.techsciresearch.com/report/anti-fungal-drugs-market/7786.html
Global Nuclear Medicine Market By Type (Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine, Brachytherapy Isotopes), By Diagnostic Nuclear Medicine (SPECT Radiopharmaceuticals v/s PET Radiopharmaceuticals), By Therapeutic Nuclear Medicine (Alpha Emitters v/s Beta Emitters), By Application (Diagnostic Applications v/s Therapeutic Applications), By Diagnostic Applications (SPECT Applications v/s PET Applications), By Therapeutic Applications (Thyroid Indications, Bone Metastasis, Lymphoma, Endocrine Tumors, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutions), By Region, Forecast & Opportunities, 2026
https://www.techsciresearch.com/report/nuclear-medicine-market/4562.html
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: sales@techsciresearch.com
Website: https://www.techsciresearch.com/
For More Market Research Blogs Visit: https://techsciblog.com/
